Mark P. Smith

1.7k citations

53 papers · 1.4k · h-index 25

Impact in

Hematology top 1%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management

Papers in

Hematology 38
- Hemophilia Treatment and Research 25
- Platelet Disorders and Treatments 10
- Blood Coagulation and Thrombosis Mechanisms 3
Genetics 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
- Genomic variations and chromosomal abnormalities 2

Co-authors: Geoffrey F. Savidge (15 shared papers)Peter Myles George (8 shared papers)Gary W. Moore (4 shared papers)Lucy Norris (2 shared papers)J. Bonnar (2 shared papers)Philip J. Steer (2 shared papers)Andrew D. Laurie (4 shared papers)Christopher A. Ludlam (2 shared papers)
Journals: Haemophilia (8 papers)Blood Coagulation & Fibrinolysis (5 papers)British Journal of Haematology (5 papers)Journal of Thrombosis and Haemostasis (3 papers)Thrombosis and Haemostasis (3 papers)
Partner nations: New Zealand United Kingdom United States

In The Last Decade

Mark P. Smith

53 papers receiving 1.4k citations

Peers

Countries citing papers authored by Mark P. Smith

Since Specialization

Citations

This map shows the geographic impact of Mark P. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Smith more than expected).

Fields of papers citing papers by Mark P. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Smith. The network helps show where Mark P. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark P. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark P. Smith Line = papers co-authored together Mark P. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia Nature Genetics ·Ian M. Morison, Elisabeth Martin Cramer, Emma J. Cheesman, Pak Leng Cheong, Andrew Holyoake, Serge Fichelson, Robert J. Weeks, Alexandra Lo	2008	152
2	Tinzaparin sodium for thrombosis treatment and prevention during pregnancy American Journal of Obstetrics and Gynecology ·Mark P. Smith, Lucy Norris, Philip J. Steer, Geoffrey F. Savidge, J. Bonnar	2004	78
3	Clinical evaluation of moroctocog alfa (AF‐CC), a new generation of B‐domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full‐length recombinant factor VIII Haemophilia ·Michael Recht, László Nemes, Michal J. Matysiak, Marilyn J. Manco‐Johnson, Jeanne M. Lusher, Mark P. Smith, Pier M. Mannucci, C. R. M. Hay	2009	77
4	A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation British Journal of Haematology ·Christopher A. Ludlam, Mark P. Smith, Massimo Morfini, A. Gringeri, Elena Santagostino, Geoffrey F. Savidge	2003	68
5	Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII Thrombosis and Haemostasis ·Christopher A. Ludlam, Peter W. Collins, C. R. M. Hay, Jonathan T. Wilde, Alessandro Grigeri, Tina Melsen, Geoffrey F. Savidge, Mark P. Smith	2001	63
6	Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer Journal of Clinical Oncology ·Karim S. Fizazi, Michel Pierre Ducreux, Pierre Ruffiè, M. Bonnay, Jean‐Charles Soria, Catherine Hill, Abderrahim Fandi, Marc Poterre	2000	59
7	Immune Tolerance Therapy for Haemophilia A Patients with Acquired Factor VIII Alloantibodies: Comprehensive Analysis of Experience at a Single Institution Thrombosis and Haemostasis ·E. L. Waters, R. Beresford-Webb, Michael J. Mitchell, Anwar Alhaq, Simon A Brown, Geoffrey F. Savidge, Mark P. Smith +2 others	1999	53
8	Double complex mutations involvingF8andFUNDC2caused by distinct break-induced replication Human Mutation ·Campbell R. Sheen, Ursula R. Jewell, Christine M. Morris, Stephen O. Brennan, Claude Férec, Peter Myles George, Mark P. Smith, Jian‐Min Chen	2007	48
9	The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants Blood Coagulation & Fibrinolysis ·Gary W. Moore, Mark P. Smith, Geoffrey F. Savidge	2003	44
10	ReFacto®1 and Advate®2: a single‐dose, randomized, two‐period crossover pharmacokinetics study in subjects with haemophilia A Haemophilia ·Mark P. Smith, Robert Klamroth, Pier M. Mannucci, Carl Kollmer, J. Feingold, C. M. Kessler, H. Pöllmann, Massimo Morfini	2007	44
11	Immune Tolerance Therapy for Haemophilia Drugs ·Aloysius Yew Leng Ho, Susan E. Height, Mark P. Smith	2000	43
12	Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy Thrombosis and Haemostasis ·J. Bonnar, Mark P. Smith, Philip J. Steer, Geoff Savidge, Lucy Norris	2004	40
13	Detection of Factor VIII Gene Mutations by High-Resolution Melting Analysis Clinical Chemistry ·Andrew D. Laurie, Mark P. Smith, Peter Myles George	2007	39
14	Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE® in patients with von Willebrand’s disease: a prospective multi‐centre study Haemophilia ·Scott M. Dunkley, Ross Ian Baker, Michael Pidcock, Jamie Price, Michael Seldon, Mark P. Smith, Alison Street, Giulio Barrese	2010	38
15	Physician assessments of practice patterns in emergency department radiograph interpretation Annals of Emergency Medicine ·Margaret R. O'Leary, Mark P. Smith, William W. Olmsted +1 other	1988	34
16	7 Megakaryocytes and platelets in α-granule disorders Baillière s Clinical Haematology ·Mark P. Smith, Elisabeth Martin Cramer, Geoffrey F. Savidge	1997	32
17	Genomic anatomy of the Tyrp1 (brown) deletion complex Proceedings of the National Academy of Sciences ·Ian Smyth, Laurens G. Wilming, Angela Lee, Martin S. Taylor, Phillipe Gautier, Karen F. Barlow, Justine Wallis, Sancha Martin	2006	31
18	Differential identification of a rare form of platelet‐type (pseudo‐) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin‐induced‐platelet‐agglutination mixing assay and confirmed by genetic analysis British Journal of Haematology ·Emmanuel J. Favaloro, David M. Patterson, Anna Denholm, Scott Mead, Ann Gilbert, Jane A. Estell, Peter Myles George, Mark P. Smith +1 other	2007	31
19	Preimplantation genetic diagnosis for hemophilia A using indirect linkage analysis and direct genotyping approaches Journal of Thrombosis and Haemostasis ·Andrew D. Laurie, A. M. Hill, James R Harraway, ANDREW P. FELLOWES, G.T. PHILLIPSON, Peter S. Benny, Mark P. Smith, Peter Myles George	2010	30
20	Heterozygous factor XI deficiency associated with three novel mutations British Journal of Haematology ·Michael J. Mitchell, Jacky A. Cutler, Gary W. Moore, E J ap Rees, Mark P. Smith, Geoffrey F. Savidge, Anwar Alhaq +1 other	1999	29

About Mark P. Smith

Mark P. Smith is a scholar working on Hematology, Genetics, Internal Medicine, Biochemistry and Immunology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (25 papers), Platelet Disorders and Treatments (10 papers), Complement system in diseases (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Blood transfusion and management (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Hematology (851 citations), Internal Medicine (97 citations), Genetics (65 citations), Biochemistry (36 citations) and Rheumatology (61 citations). Mark P. Smith has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include Geoffrey F. Savidge, Peter Myles George, Gary W. Moore, Lucy Norris, J. Bonnar, Philip J. Steer, Andrew D. Laurie, Christopher A. Ludlam, Elisabeth Martin Cramer and Anwar Alhaq. Their work appears in journals such as Haemophilia, Blood Coagulation & Fibrinolysis, British Journal of Haematology, Journal of Thrombosis and Haemostasis and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark P. Smith

Impact in

Papers in i

In The Last Decade

Mark P. Smith

Peers

Countries citing papers authored by Mark P. Smith

Fields of papers citing papers by Mark P. Smith

All Works

About Mark P. Smith

Explore authors with similar magnitude of impact

Papers in